NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Mild-to-moderate essential hypertension with type 2 diabetes
Date of first enrollment	05/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Calblock tablet(Azelnidipine)|Acecol tablet(Temocapril Hydrochloride) INN of investigational material : azelnidipine/Temocapril Therapeutic category code : 214 Antihypertensives Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Efficacy and safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 30age old
Age maximum	<= 79age old
Gender	Both
Include criteria	Inclusion criteria: -Patient, age 30-79 -Blood pressure: stable, mean SBP >= 140 and <180 mmHg, and mean DBP >= 90 and <110 mmHg.
Exclude criteria	Exclusion criteria: -Secondary hypertension or malignant hypertension -Cerebrovascular disease and cardiovascular disease -Patient with poor glycemic control